Search Results - "GREGSON, N. A."

Refine Results
  1. 1

    A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy by Hughes, R. A. C., Umapathi, T., Gray, I. A., Gregson, N. A., Noori, M., Pannala, A. S., Proteggente, A., Swan, A. V.

    Published in Brain (London, England : 1878) (01-08-2004)
    “…To investigate the aetiology of chronic idiopathic axonal polyneuropathy (CIAP), 50 consecutive patients were compared with 50 control subjects from the same…”
    Get full text
    Journal Article
  2. 2

    Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit by SILBER, E, SEMRA, Y. K, GREGSON, N. A, SHARIEF, M. K

    Published in Neurology (14-05-2002)
    “…The cause of axonal loss, an important contributor to disability in MS, is poorly understood. This study investigated whether progression in MS is associated…”
    Get full text
    Journal Article
  3. 3

    Pathogenesis of Guillain–Barré syndrome by Hughes, R.A.C, Hadden, R.D.M, Gregson, N.A, Smith, K.J

    Published in Journal of neuroimmunology (01-12-1999)
    “…Recent neurophysiological and pathological studies have led to a reclassification of the diseases that underlie Guillain-Barré syndrome (GBS) into acute…”
    Get full text
    Journal Article
  4. 4

    Paraneoplastic stiff person syndrome with metastatic adenocarcinoma and anti-Ri antibodies by MCCABE, D. J. H, TURNER, N. C, CHAO, D, LEFF, A, GREGSON, N. A, WOMERSLEY, H. J, MAK, I, PERKIN, G. D, SCHAPIRA, A. H. V

    Published in Neurology (27-04-2004)
    “…A 43-year-old woman presented with clinical and electrophysiologic features of stiff person syndrome (SPS), without abdominal or lumbar paraspinal muscle…”
    Get full text
    Journal Article
  5. 5

    Campylobacter jejuni Infection and Guillain–Barré Syndrome by Rees, Jeremy H, Soudain, Sara E, Gregson, Norman A, Hughes, Richard A.C

    Published in The New England journal of medicine (23-11-1995)
    “…Guillain–Barré syndrome is the most common cause of acute neuromuscular paralysis, 1 yet its cause and pathogenesis are unknown. In approximately two thirds of…”
    Get full text
    Journal Article
  6. 6

    Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration by Demestre, M, Wells, G.M, Miller, K.M, Smith, K.J, Hughes, R.A.C, Gearing, A.J, Gregson, N.A

    Published in Neuroscience (2004)
    “…The effect of treatment with a broad-spectrum inhibitor (BB1101) of the matrix metalloproteinases (MMPs) on nerve regeneration and functional recovery after…”
    Get full text
    Journal Article
  7. 7

    Characterization of matrix metalloproteinases in denervated muscle by Demestre, M., Orth, M., Wells, G. M., Gearing, A. J., Hughes, R. A. C., Gregson, N. A.

    Published in Neuropathology and applied neurobiology (01-10-2005)
    “…In a nerve crush model of denervation, we examined muscle matrix metalloproteinase (MMP) expression, localization and activity. In normal muscle, MMP mRNA…”
    Get full text
    Journal Article
  8. 8

    A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks by Lefaucheur, J-P, Gregson, N A, Gray, I, von Raison, F, Bertocchi, M, Créange, A

    “…Objective:Multifocal motor neuropathy with persistent conduction blocks is classically described as a chronic neuropathy with progressive onset, and acute…”
    Get full text
    Journal Article
  9. 9

    Anti-PMP22 antibodies in patients with inflammatory neuropathy by Gabriel, C.M, Gregson, N.A, Hughes, R.A.C

    Published in Journal of neuroimmunology (01-05-2000)
    “…An experimental model of inflammatory radiculoneuropathy is induced by immunising rats with peripheral myelin protein 22 (PMP22). We have investigated whether…”
    Get full text
    Journal Article
  10. 10

    A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-α processing attenuates experimental autoimmune neuritis by REDFORD, E. J, SMITH, K. J, GREGSON, N. A, DAVIES, M, HUGHES, P, GEARING, A. J. H, MILLER, K, HUGHES, R. A. C

    Published in Brain (London, England : 1878) (01-10-1997)
    “…Matrix metalloproteinases (MMPs) and the cytokine tumour necrosis factor (TNF)-alpha are implicated in the pathology of inflammatory demyelinating diseases of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The distribution of CD1 molecules in inflammatory neuropathy by Khalili-Shirazi, A., Gregson, N.A., Londei, M., Summers, L., Hughes, R.A.C.

    Published in Journal of the neurological sciences (30-06-1998)
    “…The CD1 molecules have been shown to present non-protein antigens, such as complex lipids to Mycobacteria, and may be important in presenting glycolipids which…”
    Get full text
    Journal Article
  13. 13

    Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome by Dilley, A, Gregson, N.A, Hadden, R.D.M, Smith, K.J

    Published in Journal of neuroimmunology (01-06-2003)
    “…The efficacy of plasma exchange as a therapy for Guillain-Barré syndrome (GBS) suggests that humoral factors might contribute to the axonal conduction block…”
    Get full text
    Journal Article
  14. 14

    Haemophilus influenzae as a possible cause of Guillain–Barré syndrome by Ju, Y.Y, Womersley, H, Pritchard, J, Gray, I, Hughes, R.A.C, Gregson, N.A

    Published in Journal of neuroimmunology (01-04-2004)
    “…Recent reports have contained conflicting results on the relationship between antecedent Haemophilus influenzae infection and Guillain–Barré syndrome (GBS). To…”
    Get full text
    Journal Article
  15. 15

    Human immunoglobulin ameliorates rat experimental autoimmune neuritis by GABRIEL, C. M, GREGSON, N. A, REDFORD, E. J, DAVIES, M, SMITH, K. J, HUGHES, R. A. C

    Published in Brain (London, England : 1878) (01-09-1997)
    “…Human immunoglobulin is an effective treatment for Guillain-Barré syndrome, although the mechanism of action is not understood. We have investigated the effect…”
    Get full text
    Journal Article
  16. 16

    The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia : comparative clinical, immunological and nerve biopsy findings by YEUNG, K. B, THOMAS, P. K, KING, R. H. M, WADDY, H, WILL, R. G, HUGHES, R. A. C, GREGSON, N. A, LEIBOWITZ, S

    Published in Journal of neurology (01-10-1991)
    “…Observations have been made on a consecutive series of 62 patients with peripheral neuropathy associated with benign monoclonal paraproteinaemia. The…”
    Get full text
    Journal Article
  17. 17

    Accumulation of immunoglobulin across the 'blood-nerve barrier' in spinal roots in adoptive transfer experimental autoimmune neuritis by Hadden, R. D. M., Gregson, N. A., Gold, R., Smith, K. J., Hughes, R. A. C.

    Published in Neuropathology and applied neurobiology (01-12-2002)
    “…At the onset of Guillain–Barré syndrome, disruption of diffusion barriers, such as the blood–nerve barrier, probably increases the exposure of spinal roots and…”
    Get full text
    Journal Article
  18. 18

    A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization by CHANTRY, A, GREGSON, N. A, GLYNN, P

    Published in The Journal of biological chemistry (25-12-1989)
    “…Brain myelin membrane preparations contain a metalloproteinase activity which degrades myelin basic protein (MBP). The activity was associated with lentil…”
    Get full text
    Journal Article
  19. 19

    Efficacy of leukemia inhibitory factor in experimental autoimmune neuritis by Laurà, M, Gregson, N.A, Curmi, Y, Hughes, R.A.C

    Published in Journal of neuroimmunology (01-12-2002)
    “…Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that exerts neurotrophic and myotrophic actions. We have investigated the effect of LIF in…”
    Get full text
    Journal Article
  20. 20